Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 51–100 of 139 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05024734	Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids(GAIN-INST)	active not recruiting	Phase 2	31	Roland Seiler-BlarerOTHER	1	Jul 13, 2026	clinicaltrials
NCT05644041	Intravesical Gem/Doce in Patients With NMIBC	active not recruiting	Phase 2	31	University of ArizonaOTHER	1	Jul 13, 2026	clinicaltrials